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Bakhtiyari et al. report on the natural direct and indirect effects of adiposity on cardiovascular disease (CVD) in the Tehran Lipid and Glucose Study. 1 The authors applied a mediation analysis based on theory of causal inference, 2 a modern approach to investigating disease pathways in observational research on the population level. 3 Methods of mediation analysis enable the decomposing of the total effect of an exposure on an outcome in its natural direct and indirect effects. 4 The total effect captures the exposure-outcome relationship via all involved causal pathways. Its effect measure indicates the potential impact of interventions targeting the exposure of interest in the study population. The natural direct and indirect effects from mediation analysis capture the exposure-outcome relationship via the direct pathway and via intermediate factors, so-called mediators. Of note, natural direct and indirect effects sum up to the total effect. Figure 1 shows a directed acyclic graph and the corresponding pathways and effects. Natural effects thus break down the total effect and describe the underlying mechanisms linking the exposure with the outcome. Mechanisms operating via mediators of relative importance suggest that refinement of interventions targeting these mediators may represent a promising strategy. 5 Precisely formulating the research question, that is, whether the study aims to target the total effect or to focus on indirect or mediating effects to understand mechanisms of the exposure-outcome action, obviously is the prerequisite for choosing the proper analyses and the reporting of the effect measure.
Bakhtiyari et al. aimed to decompose the total effect of central and general adiposity on CVD considering blood pressure, cholesterol and glucose as mediating factors. The analysed population-based cohort study consisted of 6280 women and men 30 years of age. Mean body mass index (BMI) and waist circumference at baseline were 27.5 kg/m 2 and 90.6 cm, respectively. Over 13.9 years of follow-up, 710 CVD events occurred. The study provides valuable insights into the adiposity-CVD relationship, identifying cholesterol as the most important mediator of the effect of obesity (BMI 30 kg/m 2 ) on CVD with a natural indirect effect hazard ratio per 1 mmol/l of 1.35 (95% confidence interval (CI) 1.12-1.62). Further, the authors report first results on the natural indirect effects of central adiposity (defined as waist circumference > 90 cm for both men and women in the Iranian population) on CVD, revealing blood pressure as the most important mediating factor (hazard ratio per 10 mmHg of 1.15 (95% CI 1.07-1.24)). These natural indirect effect estimates translate into proportions of the total effect of obesity and central adiposity mediated by cholesterol and blood pressure of 65% (95% CI 35-91%) and 36% (95% CI 17-72%). Relevant mediating effects identified are also exerted by cholesterol in central adiposity and glucose in central, but not in general, adiposity, which may relate to the study population's mean waist circumference and BMI and the resulting statistical power of the analysis. The total effects of obesity and central adiposity on CVD were also reported and amounted to hazard ratios of 1.67 (95% CI 1.07-2.26) and 1.59 (95% CI 1.26-2.01), respectively.
General and central accumulation of body fat have causal effects on CVD, 6 yet the underlying mechanisms linking adiposity with CVD are not well understood. Using natural direct and indirect effect estimates is the proper choice for research with the motivation to improve the understanding of these mechanisms. The paper by Bakhtiyari et al. provides further evidence on causal pathways between adiposity and CVD that adds to the current literature. At least two important issues generally require consideration when conducting mediation analysis and interpreting its results that also concern the study at hand.
First, four conditions should be satisfied when estimating natural direct and indirect effects. These comprise: (1) no unmeasured exposure-outcome confounding given, (2) no unmeasured mediator-outcome confounding given, (3) no unmeasured exposuremediator confounding given, and (4) no effect of the exposure that confounds the mediator-outcome relationship. 7 It is impossible to verify these assumptions, particularly the last, as they are not directly observable in empirical settings. However, while it is generally argued that confounding is present in any observational study, causal set up and proper analyses allow causal interpretation. 2 In the work by Bakhtiyari et al., information on dietary factors and alcohol consumption was unavailable, and these unmeasured variables could lead to mediator-outcome confounding. However, the authors extensively investigated the robustness of their study findings to possible unmeasured confounding, including dietary intake, in the sensitivity analysis. Restricting the analysis to non-smokers had the strongest influence on the size of effect estimates, suggesting the presence of unmeasured exposure-outcome confounding at least to some extent. Subclinical vascular disease may also play a role in this regard. Whether mediation analyses adequately meet the required assumptions is a matter of continuous debate. Given that the underlying conditions of mediation analysis are satisfied, the study results from Bakhtiyari et al., which are consistent with findings of a study that investigated metabolic mediators of the obesity-coronary heart disease relationship, 8 add to the further understanding of causal pathways linking adiposity with CVD.
Second, mediation analysis reaches beyond the common grounds of public health research by holding fixed both the level of the mediator (when estimating natural direct effects) and the level of the exposure (when estimating natural indirect effects). This makes natural direct and indirect effects difficult to interpret and corresponding interventions hard to conceive. In the study by Bakhtiyari et al., for example, the natural direct effect hazard ratio of obesity is 1.23 (95% CI 0.81-1.86) and expresses the CVD risk of obese persons as compared with normal weight persons, if the obese had the cholesterol level of normal weight persons. The above-mentioned 1.35 natural indirect effect hazard ratio of obesity mediated by cholesterol, however, expresses the CVD risk of obese persons with their actual cholesterol level as compared with the CVD risk of obese persons if their cholesterol level were that of normal weight persons. The resulting two scenarios -where obese persons show both their own cholesterol levels and those of normal weight persons -are incompatible. The results of mediation analysis thus have implications for the statistical models of its origins, but limited implications at the population level. 9 Total effects certainly are of greater value for public health than natural direct and indirect effects since implying, if generalizable, targeted interventions for a given exposure in the population. From this perspective, the total effects of general and central adiposity on CVD reported by Bakhtiyari et al. better serve the purpose of research addressing public health questions. Whether refining interventions targeting the identified mediators of the adiposity-CVD relationship will eliminate or lower the indirect effects of adiposity on CVD remains to be investigated by further research.
The natural direct and indirect effect estimates from the mediation analysis reported by Bakhtiyari et al. further elucidate, under specific assumptions, the underlying causal pathways from adiposity exposures to CVD outcomes. The total effect estimates for adiposity on CVD also presented by the authors remain, however, the main and key effect measures of interest for research transferable to CVD prevention and public health.
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